Company
Avelo
Making every breath count – closing the gap in respiratory disease diagnostics with breath sampling
Also known as Avelo AG
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Legal name
- Avelo AG
- avelolife.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Avelo's mission is to close the diagnostic gap in respiratory disease, so that every patient receives the timely, accurate information they need to be treated effectively.
Funding snapshot
- Total raised
- $114MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $8.2M2024-12-31
Funding rounds
- Round, 2024
- $8.2M2024-12-31, SEC form D sold, 35 investors
- Round, 2022
- $18.3M2022-12-13, SEC form D sold, 20 investors
- Round, 2020
- $87.7M2020-01-16, SEC form D sold, 124 investors
Products
- Hardware
- AveloMask
Loading relationship preview